Tag

Tagged: personalised medicine

Sponsored
10 years, 3 months ago

How effective is data sharing across different medical institutions, communities, and contexts?

David Bowtell
Directory:
Cancer
Tags:
cancer genetics
cancer research
data flow
data sharing
EUTROC
information capture
IT systems
personalised medicine
tumour banking
view in full page
10 years, 3 months ago

Why is enhanced collaboration between professional bodies important for personalised medicine?

David Bowtell
Directory:
Cancer
Tags:
cancer drugs
cancer genetics
cancer research
cancer treament
EUTROC
genetic mutations
personalised medicine
pharmaceutical companies
view in full page
10 years, 3 months ago

How do genetic mutations translate into personalised medicine?

David Bowtell
Directory:
Cancer
Tags:
biomarkers
cancer care
cancer cells
cancer genetics
cancer treatment
EUTROC
genetic mutations
ovarian cancer
personalised medicine
view in full page
10 years, 3 months ago

How does personalised medicine affect the doctor-patient relationship?

Hani Gabra
Directory:
Cancer
Tags:
cancer care
EUTROC
molecular profiling
ovarian cancer
personalised medicine
quality of life
tailored treatment
view in full page
10 years, 3 months ago

Why are communications important for treating ovarian cancer?

Hani Gabra
Directory:
Cancer
Tags:
cancer
cancer care
cancer research
EUTROC
intradisciplinary communication
ovarian cancer
personalised medicine
rare cancer
view in full page
10 years, 3 months ago

What are the limitations of personalised medicine?

Hani Gabra
Directory:
Cancer
Tags:
adaptive trial designs
Bayesian statistics
biomarkers
cancer care
EUTROC
personalised medicine
randomised clinical trials
view in full page
10 years, 3 months ago

What is EUTROC and why was it set up?

Hani Gabra
Directory:
Cancer
Tags:
clinical research
clinical studies
EUTROC
ovarian cancer
personalised medicine
translational medicine
view in full page
joined 10 years, 6 months ago

Christophe Le Tourneau

Medical Oncologist, Head of the Phase I Program, Institut Curie, Paris ยท Department of Medical Oncology
Directory:
Cancer
Expertise:
EUTROC
molecular abnormalities
molecular biology
ovarian cancer
personalised medicine
randomised trials

Dr Christophe Le Tourneau is Head of the Phase I Program Institut Curie, Paris.


view this profile
13 years, 2 months ago

Can platinum resistance be overcome by changing drugs?

Mike Birrer
Directory:
Cancer
Tags:
avastin
bevacizumab
chemotherapy
docetaxel
ovarian cancer
personalised medicine
targeted therapies
view in full page
13 years, 2 months ago

Is personalised medicine economically viable?

Mike Birrer
Directory:
Cancer
Tags:
personalised medicine
standard of care
targeted therapy
view in full page
load more Loading..